American Century Companies’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-154,700
Closed -$391K 2993
2023
Q4
$391K Buy
154,700
+45,835
+42% +$107K ﹤0.01% 2463
2023
Q3
$260K Buy
108,865
+32,909
+43% +$72.9K ﹤0.01% 2504
2023
Q2
$175K Buy
75,956
+42,025
+124% +$119K ﹤0.01% 2559
2023
Q1
$82.1K Buy
33,931
+15,243
+82% +$43.7K ﹤0.01% 2572
2022
Q4
$46.9K Buy
+18,688
New +$52.1K ﹤0.01% 2541

American Century Companies's SLGC Position: Q1 2024 in Review

American Century Companies sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 154,700 shares — an estimated $391K sold.

American Century Companies first reported a position in SLGC in Q4 2022 and held it in 5 quarters. The position peaked at $391K in Q4 2023. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • American Century Companies reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • American Century Companies sold 154,700 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $391K.
  • American Century Companies first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2022 and held it in 5 quarters.
  • American Century Companies's SomaLogic, Inc. Class A Common Stock position peaked at $391K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.